# SK Capital Partners

> SK Capital Partners is a VC fund backing Manufacturing and Biotechnology. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 7
- Last investment: Sep 2022
- Lead investor: 71%
- Last updated: Aug 2026
- X (Twitter): http://twitter.com/SKCapital
- Website: http://www.skcapitalpartners.com

SK Capital Partners is a sector-focused private investment firm that utilizes a transformational approach to value creation. The firm is led by five Managing Directors who collectively have substantial industry, operating, and investment experience in the specialty materials, chemicals, and healthcare sectors.

## Contacts

5 contacts available for SK Capital Partners. Shizune tracks 11 team members at SK Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sk-capital-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 4 | 57% |
| Biotechnology | 2 | 29% |
| Pharmaceutical | 2 | 29% |
| Medical | 1 | 14% |
| Genetics | 1 | 14% |

8 industries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jonathan Borell | Managing Director | 3 | — |
| Josh Lieberman | Vice President | 0 | — |
| Mario Toukan | Managing Director | 2 | — |
| Aaron Davenport | Managing Director | 1 | — |
| Barry Penney | Managing Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Techmer PM | Techmer PM is a plastics company that manufactures colors and additives. |  | Private Equity | Sep 07, 2022 |  |
| Techmer PM | Techmer PM is a plastics company that manufactures colors and additives. |  | Private Equity | Sep 07, 2022 |  |
| VanDeMark Chemical | VanDeMark is dedicated to providing products and services that enhance the quality and performance of our customers' products. Quality assurance and continuous improvement are emphasized throughout all levels of the organization. These Core Business Competencies are promoted by means of communication that builds teamwork and professionalism,and by a learning and feedback process that encourages employee contributions. As a result, goals are met for efficiency, productivity and delivery as well as for health, safety and environmental concerns. |  | Private Equity | Sep 07, 2022 |  |
| VanDeMark Chemical | VanDeMark is dedicated to providing products and services that enhance the quality and performance of our customers' products. Quality assurance and continuous improvement are emphasized throughout all levels of the organization. These Core Business Competencies are promoted by means of communication that builds teamwork and professionalism,and by a learning and feedback process that encourages employee contributions. As a result, goals are met for efficiency, productivity and delivery as well as for health, safety and environmental concerns. |  | Private Equity | Sep 07, 2022 |  |
| Halo Pharmaceutical | Halo Pharma based in Whippany, New Jersey, is a leading provider of contract dosage form development, manufacturing, and testing services to the pharmaceutical, biotechnology, and generic industries. Like our customers, we are passionate about making a difference in the lives of patients. |  | Private Equity | Jan 06, 2015 |  |
| Spectrum Vascular | Spectrum Vascular is a medical device firm that specializes in medication management and vascular access. With its cutting-edge, superior products, Spectrum Vascular hopes to improve the lives of patients everywhere. |  | Private Equity |  |  |
| Genetix Biotherapeutics Inc. | bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaborationarrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates. |  | Private Equity |  |  |

7 of 7 investments shown.

## Co-investors
- [Vesterra Capital Partners](https://shizune.co/investors/profile/comvest-group) — VC Fund, 2 deals together
- Gryphon Investors — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does SK Capital Partners invest in?

SK Capital Partners invests primarily in Manufacturing, Biotechnology and Pharmaceutical startups, most often at Private Equity stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SK Capital Partners?

Public channels for SK Capital Partners include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SK Capital Partners?

The team at SK Capital Partners includes Jonathan Borell (Managing Director), Josh Lieberman (Vice President) and Mario Toukan (Managing Director), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co